 BlackRock Inc. cut its stake in shares of Enzo Biochem, Inc. NYSE:ENZ by 1.3 in the first quarter, according to the company in its most recent Form 13F filing with the Securities Exchange Commission. The firm owned 3,649,212 shares of the medical research companys stock after selling 49,400 shares during the period. BlackRock Inc. ... 